FASANO, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 21.802
EU - Europa 10.074
AS - Asia 5.809
SA - Sud America 588
Continente sconosciuto - Info sul continente non disponibili 158
AF - Africa 128
OC - Oceania 11
Totale 38.570
Nazione #
US - Stati Uniti d'America 21.410
IT - Italia 4.716
SG - Singapore 1.958
UA - Ucraina 1.481
CN - Cina 1.196
DE - Germania 852
VN - Vietnam 842
SE - Svezia 798
TR - Turchia 716
HK - Hong Kong 657
FI - Finlandia 488
GB - Regno Unito 477
BR - Brasile 469
IE - Irlanda 393
FR - Francia 302
RU - Federazione Russa 223
CA - Canada 165
IN - India 115
MX - Messico 93
BD - Bangladesh 81
JP - Giappone 71
BE - Belgio 51
NG - Nigeria 51
PL - Polonia 49
ES - Italia 46
NL - Olanda 44
AR - Argentina 42
CZ - Repubblica Ceca 39
ZA - Sudafrica 35
CR - Costa Rica 23
HN - Honduras 19
KR - Corea 19
EU - Europa 18
JM - Giamaica 18
PK - Pakistan 18
IQ - Iraq 17
AT - Austria 16
PE - Perù 15
CO - Colombia 14
CL - Cile 13
NI - Nicaragua 13
VE - Venezuela 12
CH - Svizzera 11
EE - Estonia 11
PR - Porto Rico 11
SA - Arabia Saudita 11
SV - El Salvador 11
EC - Ecuador 10
ID - Indonesia 10
LT - Lituania 10
PH - Filippine 10
DK - Danimarca 9
GT - Guatemala 9
IL - Israele 9
NP - Nepal 9
PT - Portogallo 9
TT - Trinidad e Tobago 9
EG - Egitto 8
RO - Romania 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
MD - Moldavia 7
MY - Malesia 7
PY - Paraguay 7
BG - Bulgaria 6
CW - ???statistics.table.value.countryCode.CW??? 6
ET - Etiopia 6
HU - Ungheria 6
JO - Giordania 6
MA - Marocco 6
TN - Tunisia 6
DZ - Algeria 5
GR - Grecia 5
HR - Croazia 5
IR - Iran 5
KZ - Kazakistan 5
OM - Oman 5
DO - Repubblica Dominicana 4
GP - Guadalupe 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
AM - Armenia 3
BO - Bolivia 3
BS - Bahamas 3
KE - Kenya 3
LB - Libano 3
MM - Myanmar 3
RS - Serbia 3
SI - Slovenia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BH - Bahrain 2
BZ - Belize 2
NO - Norvegia 2
QA - Qatar 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AL - Albania 1
BB - Barbados 1
Totale 38.414
Città #
Milan 2.938
Fairfield 2.486
Ashburn 1.880
Woodbridge 1.475
San Jose 1.450
Chandler 1.265
Jacksonville 1.146
Singapore 1.116
Seattle 1.024
Houston 1.014
Cambridge 892
Wilmington 858
Hong Kong 651
Ann Arbor 624
Council Bluffs 621
Dearborn 461
Princeton 406
Dallas 401
Dublin 381
Beijing 341
Nyköping 335
Izmir 329
Chicago 324
The Dalles 318
Boardman 279
Rome 262
Dong Ket 240
Como 230
Los Angeles 184
Lauterbourg 182
Munich 182
New York 158
San Mateo 149
Santa Clara 136
San Diego 115
Ho Chi Minh City 112
Helsinki 105
Hanoi 97
London 80
Ogden 80
São Paulo 80
Orem 71
Tokyo 64
Guangzhou 55
Hefei 52
Mexico City 52
Abuja 51
Atlanta 51
Varese 50
Brussels 49
Montreal 49
Buffalo 48
Denver 48
Phoenix 43
Warsaw 42
Washington 41
Brooklyn 38
Naples 38
Salt Lake City 37
Chennai 36
Kunming 36
San Francisco 36
Verona 36
Turku 35
Stockholm 33
Nanjing 32
Poplar 30
Falls Church 29
Paris 28
Toronto 28
Düsseldorf 27
Nanchang 27
North Bergen 27
Johannesburg 25
Amsterdam 23
Shanghai 23
Boston 22
Frankfurt am Main 22
Olomouc 22
Curitiba 21
Elk Grove Village 21
Manchester 21
Norwalk 21
Philadelphia 21
Ponte Lambro 21
Jinan 20
Berlin 18
Columbus 18
San José 18
Tampa 18
Brno 17
Redmond 17
Edinburgh 16
Miami 16
Tianjin 16
Cavaria con Premezzo 15
Shenyang 15
Shenzhen 15
Hangzhou 14
Da Nang 13
Totale 27.235
Nome #
Experimental setup for the identification of mitochondrial protease substrates by shotgun and top-down proteomics 413
Binding of Δ9-tetrahydrocannabinol and diazepam to human serum albumin 409
Changes in the two-dimensional electrophoresis pattern of the Parkinson's disease related protein DJ-1 in human SH-SY5Y neuroblastoma cells after dopamine treatment 382
Dopamine induces mitochondrial depolarization without activating PINK1-mediated mitophagy 298
Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex 291
A meta-analysis of two-dimensional electrophoresis pattern of the Parkinson's disease-related protein DJ-1 288
Human serum albumin: from bench to bedside. 278
Proteome analysis of human substantia nigra in Parkinson's disease 273
Flavonoid binding to human serum albumin. 273
Mitochondrial Proteins in the Development of Parkinson’s Disease 264
Cellular models to investigate biochemical pathways in Parkinson's disease 261
Ibuprofen binding to secondary sites allosterically modulates the spectroscopic and catalytic properties of human serum heme-albumin 259
The Depressive Phenotype Induced in Adult Female Rats by Adolescent Exposure to THC is Associated with Cognitive Impairment and Altered Neuroplasticity in the Prefrontal Cortex 258
Systems biology analysis of the proteomic alterations induced by MPP+, a parkinson's disease-related mitochondrial toxin 258
Evidence for pH-dependent multiple conformers in iron(II) heme-human serum albumin: spectroscopic and kinetic investigation of carbon monoxide binding. 256
H-1 NMR relaxometric characterization of bovine lactoferrin 245
Multiple isoforms and differential allelic expression of CHRNA5 in lung tissue and lung adenocarcinoma 245
Drugs modulate allosterically heme-fe-recognition by human serum albumin and heme-fe-mediated reactivity 244
Binding of anti-Parkinson's disease drugs to human serum albumin is allosterically modulated. 242
Allostery in a monomeric protein: the case of human serum albumin. 239
Ibuprofen and warfarin modulate allosterically ferrous human serum heme-albumin nitrosylation. 236
Isoniazid and rifampicin inhibit allosterically heme binding to albumin and peroxynitrite isomerization by heme-albumin. 235
Sequence analysis of serum albumins reveals the molecular evolution of ligand recognition properties. 231
Exploring the mitochondrial degradome by the TAILS proteomics approach in a cellular model of Parkinson's disease 231
Verification of a parkinsons disease protein signature in T-lymphocytes by multiple reaction monitoring 229
Altered dopamine homeostasis differentially affects mitochondrial voltage-dependent anion channels turnover 229
Lymphocyte proteomics of Parkinson's disease patients reveals cytoskeletal protein dysregulation and oxidative stress 227
All-trans-retinoic acid and retinol binding to the FA1 site of human serum albumin competitively inhibits heme-Fe(III) association 227
Thermodynamic analysis of hydration in human serum heme-albumin. 227
Metal complexes as allosteric effectors of human hemoglobin: An NMR study of the interaction of the gadolinium(III) bis(m-boroxyphenylamide)diethylenetriaminepentaacetic acid complex with human oxygenated and deoxygenated hemoglobin 226
Allosteric modulation of drug binding to human serum albumin 226
Abacavir and warfarin modulate allosterically kinetics of NO dissociation from ferrous nitrosylated human serum heme-albumin 225
Characterization of the c.190T>C missense mutation in BRCA1 codon 64 (Cys64Arg). 225
O2-mediated oxidation of ferrous nitrosylated human serum heme-albumin is limited by nitrogen monoxide dissociation. 225
Proteomics as a tool to investigate cell models for dopamine toxicity 224
Dopaminergic therapies modulate the T-CELL proteome of patients with Parkinson's disease 223
Discovery and verification of panels of T-lymphocyte proteins as biomarkers of Parkinson's disease 222
Towards a functional definition of the mitochondrial human proteome 222
Reductive nitrosylation of ferric human serum heme-albumin. 221
Allosteric and binding properties of Asp1-Glu382 truncated recombinant human serum albumin - an optical and NMR spectroscopic investigation 219
Systems biology analysis of the proteomic alterations in Parkinson's disease: Common and disease-specific pathways 216
Q-band EPR investigations of neuromelanin in control and Parkinson's disease patients 215
Peripheral biomarkers of Parkinson's disease as early reporters of central neurodegeneration 214
Demonstration of fibrinogen-FcRn binding at acidic pH by means of Fluorescence Correlation Spectroscopy 213
Mitochondrial proteomics investigation of a cellular model of impaired dopamine homeostasis, an early step in Parkinson's disease pathogenesis 212
Heme binding to albuminoid proteins is the result of recent evolution 211
Proteomic characterization of Jurkat T leukemic cells after dopamine stimulation: A model of circulating dopamine-sensitive cells 211
Deinococcus radiodurans' SRA-HNH domain containing protein Shp (Dr1533) is involved in faithful genome inheritance maintenance following DNA damage 211
Ligand binding to the FA3-FA4 cleft inhibits the esterase-like activity of human serum albumin 210
AN NMR-STUDY OF THE INTERACTION BETWEEN MELANIN FREE ACID AND MN2+ IONS AS A MODEL TO MIMIC THE ENHANCED PROTON RELAXATION RATES IN MELANOTIC MELANOMA 209
1H NMR RELAXOMETRIC AND OPTICAL ABSORBANCE CHARACTERIZAZION OF THE INTERACTION OF MANGANESE PORPHYRINS WITH HUMAN SERUM ALBUMIN 209
Method for the in vitro diagnosis of parkinson's disease 208
Mitochondrial alterations in Parkinson's disease human samples and cellular models 208
A systems biology-led insight into the role of the proteome in neurodegenerative diseases 208
Proteomics and renaissance: accounts of the V Italian Proteomics Association Congress, Florence 2010. 207
Allosteric modulation of anti-HIV drug and ferric heme binding to human serum albumin 207
Diagnostic Salivary Tests for SARS-CoV-2 206
Ibuprofen modulates allosterically NO dissociation from ferrous nitrosylated human serum heme-albumin by binding to three sites. 205
Isolation and C-13-NMR characterization of an insoluble proteinaceous fraction from substantia nigra of patients with Parkinson's disease 204
Molecular phylogenetic analyses of albuminoids reveal the molecular evolution of allosteric properties 204
Proteomics in Parkinson's disease: An unbiased approach towards peripheral biomarkers and new therapies 203
Integrative proteomics: perspective in complex system interpretation. 203
Ibuprofen impairs allosterically peroxynitrite isomerization by ferric human serum heme-albumin. 202
Cellular response to empty and palladium-conjugated amino-polystyrene nanospheres uptake: A proteomic study 201
Rapid salivary test suitable for a mass screening program to detect SARS-CoV-2: a diagnostic accuracy study 201
EVIDENCE FOR A GLYCIDIC-LIPIDIC MATRIX IN HUMAN NEUROMELANIN, POTENTIALLY RESPONSIBLE FOR THE ENHANCED IRON SEQUESTERING ABILITY OF SUBSTANTIA-NIGRA 200
Mn(II) binding to human serum albumin: A (1)H-NMR relaxometric study. 200
PARAMAGNETIC GD-III-FE-III HETEROBIMETALLIC COMPLEXES OF DTPA-BIS-SALICYLAMIDE 199
SYNTHESIS AND CHARACTERIZATION OF A NOVEL DTPA-LIKE GADOLINIUM(III) COMPLEX - A POTENTIAL REAGENT FOR THE DETERMINATION OF GLYCATED PROTEINS BY WATER PROTON NMR RELAXATION MEASUREMENTS 199
Saliva is a reliable tool to detect SARS-CoV-2 199
Saggio rapido per la diagnosi in vitro di infezione da SARS-CoV-2 in un fluido biologico 199
Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis 198
Is neuromelanin changed in Parkinson's disease? Investigations by magnetic spectroscopies 196
Abacavir modulates peroxynitrite-mediated oxidation of ferrous nitrosylated human serum heme-albumin 195
Toward the Standardization of Mitochondrial Proteomics: The Italian Mitochondrial Human Proteome Project Initiative 195
Pseudo-enzymatic hydrolysis of 4-nitrophenyl myristate by human serum albumin. 194
Stabilization of the T-state of human hemoglobin by proflavine, an antiseptic drug 192
Prototropic and water-exchange processes in aqueous solutions of Gd(III) chelates 192
A new ytterbium chelate as contrast agent in chemical shift imaging and temperature sensitive probe for MR spectroscopy 191
Parkinson's disease plasma biomarkers: An automated literature analysis followed by experimental validation 191
1H-NMR relaxometric analysis of drug binding effects to global unfolding of human serum albumin. 190
The five-to-six-coordination transition of ferric human serum heme-albumin is allosterically-modulated by ibuprofen and warfarin: a combined XAS and MD study. 190
Proteomica 190
Prevention and modulation of aminoglycoside ototoxicity (Review) 189
H-1-NMR relaxometric study of pancreatic serine (pro)enzyme inhibition by a Gd(III) chelate bearing boronic functionalities 188
Azide, cyanide, fluoride, imidazole and pyridine binding to ferric and ferrous native horse heart cytochrome c and to its carboxymethylated derivative: A comparative study 188
Digital and analogical reality in proteomics investigation 187
Serum heme-albumin: an allosteric protein. 186
Alpha-synuclein and Parkinson's disease: a proteomic view 185
Neonatal Fc receptor is involved in the protection of fibrinogen after its intake in peripheral blood mononuclear cells 185
Looking at COVID-19 from a Systems Biology Perspective 185
SOLID-STATE C-13 NMR CHARACTERIZATION OF MELANIN FREE ACIDS FROM BIOSYNTHETIC AND NATURAL MELANINS 184
Metodo per la diagnosi in vitro della malattia di Parkinson 183
Sviluppo di un modello cellulare della disfunzione mitocondriale nella malattia di Parkinson nella linea cellulare SH-SY5Y in seguito a trattamento con dopamina o MPP+ ed analisi proteomica dei profili di espressione proteica dei mitocondri in modelli di patologie neurodegenerative. 182
Warfarin inhibits allosterically the reductive nitrosylation of ferric human serum heme-albumin 181
NMR-STUDIES OF MELANINS - CHARACTERIZATION OF A SOLUBLE MELANIN FREE ACID FROM SEPIA INK 181
The drug-dependent five- to six-coordination transition of the heme-Fe atom modulates allosterically human serum heme-albumin reactivity 181
H-1 and O-17-NMR relaxometric investigations of paramagnetic contrast agents for MRI. Clues for higher relaxivities 179
Crystal structure and solution dynamics of the lutetium(III) chelate of DOTA 178
Reversible two-step unfolding of heme-human serum albumin: a H-1-NMR relaxometric and circular dichroism study 177
Totale 22.033
Categoria #
all - tutte 150.670
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 150.670


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.493 0 0 0 84 109 77 145 114 113 308 211 332
2022/20233.277 311 194 268 345 224 645 10 459 484 118 137 82
2023/20244.722 751 762 748 838 931 248 34 148 114 25 20 103
2024/20253.381 18 44 587 98 111 187 162 282 366 410 275 841
2025/20267.432 449 456 305 974 825 438 1.558 448 946 487 330 216
2026/20272.690 349 470 1.105 766 0 0 0 0 0 0 0 0
Totale 38.570